Effects of Olive Oil Consumption on Cardiovascular Risk Factors in Patients with Fibromyalgia
Metadatos
Afficher la notice complèteEditorial
MDPI
Materia
Cortisol Erythrocyte sedimentation rate Fibrinogen Fibromyalgia Olive oil Platelet distribution width
Date
2020-03Referencia bibliográfica
Rus, A., Molina, F., Martínez-Ramírez, M. J., Aguilar-Ferrándiz, M. E., Carmona, R., & del Moral, M. L. (2020). Effects of Olive Oil Consumption on Cardiovascular Risk Factors in Patients with Fibromyalgia. Nutrients, 12(4), 918. [doi:10.3390/nu12040918]
Patrocinador
This research was funded by Consejería de Economía, Innovación, Ciencia y Empleo (Junta de Andalucía, Spain), grant number AGR-6235.Résumé
We have recently reported that patients with fibromyalgia (FM) may be at increased risk
for cardiovascular disease. Olive oil reportedly has cardioprotective effects. We examined the
influence of olive oil consumption on cardiovascular risk factors in FM. This preliminary study
was performed on blood samples of women with FM who consumed 50 mL of organic olive oil
daily for 3 weeks. Patients were randomized into two groups: 15 women ingested extra virgin
olive oil (EVOO) and 15 refined olive oil (ROO). Cardiovascular risk markers were measured at
baseline (pre measure) and after consumption of olive oil (post measure). Red blood cell count and
erythrocyte sedimentation rate (ESR; both p < 0.05) declined significantly post-treatment in the EVOO
group. Consumption of ROO increased mean platelet volume and reduced platelet distribution width
(PDW), neutrophil-to-lymphocyte ratio, ESR and fibrinogen (all p < 0.05). Significant differences
were found in pre–post change between the EVOO and ROO groups for cortisol and PDW (both
p < 0.05). Our results have shown that consumption of olive oil may have antithrombotic and
antiinflammatory properties in patients with FM, thereby improving a number of cardiovascular risk
markers. Both EVOO and ROO may be useful as adjuvants for the prevention and/or treatment of
cardiovascular disorders in these patients.